Company page

Mesoblast Limited

Mesoblast Limited (Ticker: MSB) is a public company based in Australia, focused on developing innovative cell-based therapies. With a market capitalization of approximately AUD 2.1 billion, the company is dedicated to addressing unmet medical needs in various therapeutic areas. Mesoblast's research and development efforts aim to advance treatments for conditions such as heart disease and orthopedic disorders.